Swagat Endolaparoscopic Surgical Research Institute

Name :

Swagat Endolaparoscopic Surgical Research Institute

Address  :

A.T. Road,
Shantipur

Town  :

Guwahati

State  :

Assam

Country  :

INDIA

Post Code:

781009

Phone  :

+91 - 361 - 2131726

Fax  :

+91- 361- 2519026

Web URL  :

Swagat Endolaparoscopic Surgical Research Institute
Specialization
  • Anaesthesiology
  • Cardiology
  • Daibetes, Endocrinology
  • Gastro-enterology
  • Video Laproscopic Surgery
Facilities

Hospital Area : 20000 Square Feet

Total Number Of Beds : 50

Speciality Type :

  • Single Speciality : Endolaparoscopic Surgical

Advance Facility

  • C-arm Image Interior
  • Central O2 Facility

Description

The First Endosurgery Institute of the North East
Swagat Endolaparoscopic Surgical Research Institute is the first superspeciality surgical centre of the North East truly dedicated to the art and science of Endoscopic Surgery Conveniently located at the entry of the heart of the city at AT Road Shantipur the Hospital faces the river Brahmaputra With a built up area of 20000sq ft it is a mere 15 minutes drive from the Guwahati Airport With a 50 bedded capacity the hospital has provision for different economic segments of Society and has a team of dedicated doctors with the best of technology and environment

The very moment you step into this institute you will feel the concept of comfortable stay and care comparable to the best centres of the country and world
Cancer rising among Indias youth

More youngsters are developing cancer in India doctors said at a conference here on Thursday However most of those affected by the disease remain ignorant about it which leads to delays in diagnosis and treatment they said We are seeing more cases of cancer among teenagers and young adults However not much attention is being paid to it said Dr G... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More